155 results on '"Veach, Darren R."'
Search Results
2. Data from Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
3. Supplementary Data from Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
4. Supplementary Figure 2 from Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
5. Supplementary Figure S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
6. Figure S1 from A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
7. Supplementary Figure 1 from Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
8. Supplementary Methods from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
9. Supplementary Table S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
10. Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
11. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
12. Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
13. Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
14. Assessing Functional Androgen Receptor Pathway Activity in Response to Radiotherapy Using hK2-targeted PET Imaging
15. Abstract 3309: Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
16. Imatinib resistance and microcytic erythrocytosis in a Kit V558∆;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor
17. Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
18. Activity of Dual SRC-ABL Inhibitors Highlights the Role of BCR/ABL Kinase Dynamics in Drug Resistance
19. Loss of p53 Impedes the Antileukemic Response to BCR-ABL Inhibition
20. Cell Treatment and Lysis in 96-Well Filter-Bottom Plates for Screening Bcr-Abl Activity and Inhibition in Whole-Cell Extracts
21. A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates
22. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
23. Correction to An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy
24. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
25. PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
26. PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates
27. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
28. Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses
29. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
30. A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor
31. Synthesis and in vitro examination of [ 124I]-, [ 125I]- and [ 131I]-2-(4-iodophenylamino) pyrido[2,3- d]pyrimidin-7-one radiolabeled Abl kinase inhibitors
32. Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
33. ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts
34. Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor–Axis Imaging
35. Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles
36. Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
37. Structure–activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: Toward selective Abl inhibitors
38. Fluorine-labeled Dasatinib Nanoformulations as Targeted Molecular Imaging Probes in a PDGFB-driven Murine Glioblastoma Model
39. A magnetic bead-based protein kinase assay with dual detection techniques
40. Abstract LB-299: F-dasatinib inhibits glioma cell proliferation and alters expression of PDGFR signaling pathway intermediates in PDGFR-overexpressing glioma models
41. 124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo
42. Synthesis and Biological Evaluation of a Fluorine-18 Derivative of Dasatinib
43. DNA photocleavage and biological activity of a pyrene dihydrodioxin
44. A Cell-Based Screening Method for Resistance of Bcr-Abl Positive Leukemia Identifies the Mutation Pattern for an Alternative Abl Kinase Inhibitor.
45. Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation
46. 124I-Iodopyridopyrimidinone for PET of Abl Kinase-Expressing Tumors In Vivo.
47. Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors
48. Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation.
49. Imatinib resistance and microcytic erythrocytosis in a KitV558δ;T6691/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor.
50. SYNTHESIS AND EVALUATION OF 2,2-DIARYL-2,3-DIHYDROPHENANTHRO-[9,10-b]-1,4-DIOXIN PHOTONUCLEASES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.